Results
|
1.
|
Post-diagnosis aspirin use and survival in veterans with head and neck cancer. MedStar authors:
- Desale, Sameer
- Lumley, Catherine J
- Maxwell, Jessica H
- Tefera, Eshetu
Year: 2019
Citation: - Head & Neck. 41(5):1220-1226, 2019 05.
Institution:
- MedStar Health Research Institute
- MedStar Washington Hospital Center
Medline publication type:
All authors: - Desale S, Han CJ, Kaffenberger TM, Lumley CJ, Maxwell JH, Rafei H, Tefera E
|
|
2.
|
Importance of gender in diffuse malignant peritoneal mesothelioma. MedStar authors:
Year: 2012
Citation: - Annals of Oncology. 23(6):1494-8, 2012 Jun.
Institution: - MedStar Washington Hospital Center
Medline publication type:
- Journal Article
- Multicenter Study
All authors: - Cao C, Chua TC, Deraco M, Elias D, Glehen O, Levine EA, Moran BJ, Morris DL, Peritoneal Surface Malignancy Group, Piso P, Sugarbaker PH, Yan TD
|
|
3.
|
Twenty-five year results of the national cancer institute randomized breast conservation trial. MedStar authors:
Year: 2012
Citation: - Breast Cancer Research & Treatment. 132(1):197-203, 2012 Feb.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Camphausen K, Dan T, Danforth DN, Glatstein E, Lippman ME, Lita E, Sciuto L, Shih J, Simone NL, Smith SL, Swain SM
|
|
4.
|
Incidence of central nervous system metastases in patients with HER2-positive metastatic breast cancer treated with pertuzumab, trastuzumab, and docetaxel: results from the randomized phase III study CLEOPATRA. MedStar authors:
Year: 2014
Citation: - Annals of Oncology. 25(6):1116-21, 2014 Jun.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Baselga J, Cortes J, Im YH, Lee LF, Miles D, Quah C, Swain SM
|
|
5.
|
Dietary Modification and Breast Cancer Mortality: Long-Term Follow-Up of the Women's Health Initiative Randomized Trial. MedStar authors:
Year: 2020
Citation: - Journal of Clinical Oncology. 38(13):1419-1428, 2020 05 01.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Anderson GL, Aragaki AK, Barac A, Chlebowski RT, Johnson KC, Lane DS, Luo J, Manson JE, Mossavar-Rahmani Y, Neuhouser ML, Pan K, Prentice RL, Rohan TE, Snetselaar L, Thomson CA, Wactawski-Wende J, Women's Health Initiative
|
|
6.
|
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial. MedStar authors:
Year: 2017
Citation: - Lancet Oncology. 18(11):1493-1501, 2017 Nov
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Attia S, Baker LH, Bolejack V, Burgess M, Butterfield LH, Crowley J, D'Angelo S, Davis LE, Hu J, Lazar AJ, Maki RG, Movva S, Okuno SH, Patel S, Priebat DA, Reed DR, Reinke D, Riedel RF, Rodriguez-Canales J, Salazar R, Schuetze SM, Tawbi HA, Van Tine BA, Wistuba II
|
|
7.
|
|
|
8.
|
Continuous Combined Estrogen Plus Progestin and Endometrial Cancer: The Women's Health Initiative Randomized Trial. MedStar authors:
Year: 2016
Citation: - Journal of the National Cancer Institute. 108(3), 2016 Mar.
Institution: - MedStar Health Research Institute
Medline publication type:
- Journal Article
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
All authors: - Anderson GL, Aragaki AK, Chen C, Chlebowski RT, Haque R, Howard BV, Manson JE, Reed SD, Rohan TE, Runowicz CD, Sarto GE, Simon MS, Thomson CA, Wactawski-Wende J
|
|
9.
|
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study. MedStar authors:
Year: 2013
Citation: - Lancet Oncology. 14(6):461-71, 2013 May.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Baselga J, Benyunes MC, Campone M, Ciruelos E, Clark E, Cortes J, Ferrero JM, Kim SB, Knott A, Ro J, Ross G, Schneeweiss A, Semiglazov V, Swain SM
|
|
10.
|
Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24. MedStar authors:
Year: 2012
Citation: - Journal of Clinical Oncology. 30(12):1268-73, 2012 Apr 20.
Institution: - Washington Cancer Institute
Medline publication type:
- Comparative Study
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Allred DC, Anderson SJ, Costantino JP, Geyer CE Jr, Julian TB, Land SR, Mamounas EP, Nagtegaal ID, Paik S, Swain SM, Wickerham DL, Wolmark N
|